Graham Ross - 15 Dec 2021 Form 3 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CMO & Head of Clinical Dev.
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Graham Ross
Issuer symbol
IMMX
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
3
Filing time
15 Dec 2021, 20:01:13 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMMX Options (right to purchase) 15 Dec 2021 Common Stock 15,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 5, 2021, the Registrant issued the Reporting Person options to purchase up to 15,000 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on July 5, 2021, subject to the Reporting Person's continued service with the Registrant.

Remarks:

Exhibit List: Exhibit 24.1 - Powers of Attorney